MedTrace Logo

Palliation of Dyspnea With Mouth Piece Ventilation in AECOPD

NCT03025425 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-10-26

No results posted yet for this study

Summary

An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with acute exacerbation of COPD without acute hypercapnic respiratory failure. Subjects are recruited from the local respiratory ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.

Conditions

Interventions

DEVICE

Trilogy 100 ® (Philips Respironics)

Mouth piece Ventilation (MPV) using Trilogy 100 ® (Philips Respironics).

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Lauri Lehtimäki, MD · Tampere University Hospital, Allergy centre

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2020-08-01
Completion
2020-08-01

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025425 on ClinicalTrials.gov